Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73481985)
Watch
English
Chemotherapy for advanced non-small cell lung cancer
scientific article published on 01 June 1997
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Chemotherapy for advanced non-small cell lung cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
main subject
non-small-cell lung carcinoma
1 reference
based on heuristic
inferred from title
author
Roy S. Herbst
series ordinal
1
object named as
R S Herbst
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
author name string
N H Dang
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
A T Skarin
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
publication date
1 June 1997
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
published in
Hematology / Oncology Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
volume
11
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
page(s)
473-517
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
cites work
Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer statistics, 1994.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Results of a randomized prospective study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin dosage: prospective evaluation of a simple formula based on renal function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of metastatic non-small-cell lung cancer and a consideration of cost
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quality of life during chemotherapy in non-small cell lung cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Randomized Trial with Mitomycin-C/Ifosfamide Versus Mitomycin-C/Vindesine Versus Cisplatin/Etoposide in Advanced Non-Small-Cell Lung Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multimodal therapy for solid tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New directions for chemotherapy in non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MDR1 gene expression in lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy for advanced NSCLC. Will meta-analysis provide the answer?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of topotecan in metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-small cell lung cancer: how oncologists want to be treated
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy for advanced disease. How to raise enthusiasm.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new international staging system for lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The new International Staging System for Lung Cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sequences of taxol and cisplatin: a phase I and pharmacologic study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etoposide in the management of non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The current status of camptothecin analogues as antitumor agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vinca alkaloids in the treatment of non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The case for mitomycin in non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy in advanced lung cancer with increased survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aggressive vs nonaggressive therapy for metastatic NSCLC.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung: low response rate in a Cooperative Group Study. Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quality-of-life assessment: performance status upstaged?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970445-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8588(05)70445-7
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
PubMed ID
9209907
1 reference
stated in
Europe PubMed Central
PubMed ID
9209907
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209907%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
